Delving into the Latest Updates on NTC014 with Synapse

Overview

Basic Info

Drug Type

Small molecule drug

Synonyms

Levofloxacin + Ketorolac Trometamol, Levofloxacin/Ketorolac Trometamol, Quinolone+NSAID

+ [2]

Target-

Mechanism-

Therapeutic Areas

Infectious DiseasesEye Diseases

Active Indication

Conjunctivitis, Bacterial

Inactive Indication-

Originator Organization

NTC SRL

Active Organization

NTC SRL

Inactive Organization-

Drug Highest PhasePhase 3

First Approval Date-

Regulation-

Login to view timeline

This is a phase II, randomized, parallel-group, blinded-assessor, multicentre study to assess the non-inferiority of RD03/2016 eye drops vs. levofloxacin eye drops alone (1:1) in microbiological eradication in patients with a clinical diagnosis of bacterial conjunctivitis with moderate/severe signs.

Start Date05 Nov 2021

Sponsor / Collaborator

NTC SRL

NCT01799863 / CompletedPhase 2/3IIT

Artificial Tears Versus Preservative Free Ketorolac Trometamol 0.45% for Treatment of Acute Viral Conjunctivitis

The purpose of this study is to evaluate the evolution of the symptoms of acute viral conjunctivitis using preservative free ketorolac trometamol 0.45% associated with carboxymethylcellulose compared with isolated use of preservative-free artificial tears.

Start Date01 Jun 2012

Sponsor / Collaborator

Altino Ventura Foundation

100 Clinical Results associated with NTC014

Login to view more data

100 Translational Medicine associated with NTC014

Login to view more data

100 Patents (Medical) associated with NTC014

Login to view more data

100 Deals associated with NTC014

Login to view more data